Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques
  2. Kennedy, P. E.; Bera, T. K.; Wang, Q. C.; Gallo, M.; Wagner, W.; Lewis, M. G.; Berger, E. A.; Pastan, I.
  3. Journal of Leukocyte Biology. 2006, Nov; 80(5): 1175-1182.
  1. 2.   Antisense treatments for biothreat agents
  2. Warfield, K. L.; Panchal, R. G.; Aman, M. J.; Bavari, S.
  3. Current Opinion in Molecular Therapeutics. 2006, Apr; 8(2): 93-103.
  1. 3.   HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+T-cells
  2. Cicala, C.; Arthos, J.; Censoplano, N.; Cruz, C.; Chung, E.; Martinelli, E.; Lempicki, R. A.; Natarajan, V.; VanRyk, D.; Daucher, M.; Fauci, A. S.
  3. Virology. 2006, FEB 5; 345(1): 105-114.
  1. 4.   Effects of Gag mutation and processing on retroviral dimeric RNA maturation
  2. Fu, W.; Dang, Q.; Nagashima, K.; Freed, E. O.; Pathak, V. K.; Hu, W. S.
  3. Journal of Virology. 2006, FEB; 80(3): 1242-1249.
  1. 5.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 6.   Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture
  2. Huleihel, M.; Talishanisky, M.; Ford, H.; Marquez, V. E.; Kelley, J. A.; Johns, D. G.; Agbaria, R.
  3. International Journal of Antimicrobial Agents. 2005, MAY; 25(5): 427-432.
  1. 7.   Association of Ebola virus matrix protein VP40 with microtubules
  2. Ruthel, G.; Demmin, G. L.; Kallstrom, G.; Javid, M. P.; Badie, S. S.; Will, A. B.; Nelle, T.; Schokman, R.; Nguyen, T. L.; Carra, J. H.; Bavari, S.; Aman, M. J.
  3. Journal of Virology. 2005, APR; 79(8): 4709-4719.
  1. 8.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 9.   A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types
  2. Lueders, K. K.; De Rosa, S. C.; Valentin, A.; Pavlakis, G. N.; Roederer, M.; Hamer, D. H.
  3. Aids Research and Human Retroviruses. 2004 20(2): 145-150.
  1. 10.   Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy
  2. Yang, Q.
  3. Medical Hypotheses. 2004 62(3): 358-363.
  1. 11.   Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys
  2. Alexander, L.; Illyinskii, P. O.; Lang, S. M.; Means, R. E.; Lifson, J.; Mansfield, K.; Desrosiers, R. C.
  3. Journal of Virology. 2003 77(12): 6823-6835.
  1. 12.   Peptide nucleic acids as epigenetic inhibitors of HIV-1
  2. Sei, S.
  3. Letters in Peptide Science. 2003 10(3-4): 269-286.
  1. 13.   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
  2. Chertova, E.; Bess, J. W.; Crise, B. J.; Sowder, R. C.; Schaden, T. M.; Hilburn, J. M.; Hoxie, J. A.; Benveniste, R. E.; Lifson, J. D.; Henderson, L. E.; Arthur, L. O.
  3. Journal of Virology. 2002 76(11): 5315-5325.
  1. 14.   Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain
  2. Sei, S.; Yang, Q. E.; O'Neill, D.; Yoshimura, K.; Nagashima, K.; Mitsuya, H.
  3. Journal of Virology. 2000 74(10): 4621-4633.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel